Skip to main content

Market Overview

MassMEDIC's IGNITE MedTech Virtual Accelerator Announces 2020 MedTech IGNITE Cohort


BOSTON, June 8, 2020 /PRNewswire-PRWeb/ -- The Massachusetts Medical Device Industry Council (MassMEDIC) announced today the MedTech IGNITE Growth Challenge 2020 Cohort. This year's cohort of 21 ventures—representing medtech start-ups from across the Commonwealth and beyond—are developing novel technologies in a wide range of categories including women's health, telehealth, surgical, combination devices, pediatrics, mental health, digital diagnostics, audiology, and oncology.

The MedTech IGNITE Program is a virtual accelerator offering an experiential training, mentorship, and networking curriculum, to attract and nurture the next generation of Boston-area medtech founders and entrepreneurs. IGNITE was relaunched in 2019 with a cohort of 16 companies and support from a grant from the Massachusetts Life Sciences Center (MLSC). Several 2019 cohort members went on to win significant prizes including MassChallenge and the BRIght Futures Prize. This year's program, with the support of sponsors Propel, Alira Health, Boyd Technologies and the MLSC, will offer similar workshops, bootcamps, mentoring and networking opportunities, all conducted virtually.

"Although this year's IGNITE program will be conducted virtually, it promises to continue being the premier accelerator focused on development and support of the medtech start-up community in Massachusetts. We are confident that this year's cohort, as in previous years, will benefit from access to our community of experts, mentors and industry leaders and CEOs," said Brian Johnson, President of MassMEDIC. "We look forward to launching this year's program with an Entrepreneur Boot Camp and introducing the 2020 IGNITE Cohort to the greater medtech community this fall during the MassMEDIC MedTech Showcase."

The MedTech IGNITE 2020 cohort includes:

Agile Devices (Wellesley)
Beacon Biomimetics (Cambridge)
Biomembretics (Boston)
Burnie, Inc. (Boise, ID)
Cellens (Medford)
CreatSens (Tarragona, Spain)
Cosm (Toronto, Canada)
Embr Labs (Boston)
FeinsRing (Boston)
Incasa Healthcare (Wellesley)
LivOnyx (Allston and Lowell)
Medsix (Boston)
Nesa Medtech (Bangalore, India)
Qanik DX (Ontario, Canada)
RBI Medical (Boston)
RevMedica (New Haven, CT)
Strategen Bio (Cambridge)
UV Light Care (Boston)
VeraDermix (Waltham)
Walkky (Brookline)
Xander (Somerville)

Over the course of the 2020 IGNITE program, the Cohort will attend workshops and tutorials; matched with a mentor; introduced to potential investors and advisors; and have the opportunity to learn from CEOs during "fireside chat" type events. In addition, they will vie for up to $70,000 in cash and services. MassMEDIC thanks our sponsors, Alira Health, Propel, Boyd Technologies and the Massachusetts Life Sciences Center

To join and connect with the MedTech IGNITE Community and to learn more about the 2020 Cohort, visit: and click on Go to Challenge.

# # #

About MassMEDIC:
The Massachusetts Medical Device Industry Council (MassMEDIC), an organization of more than 300 manufacturers, suppliers, research institutions, and academic health centers, promotes the unique interests of the Bay State's growing and vibrant medical device sector. Through a variety of programs, informational seminars, advocacy campaigns and other projects, MassMEDIC provides medical device manufacturers and suppliers with information on industry trends and regulatory policies and creates forums that allow members to exchange ideas and information on issues affecting the industry. For more information on MassMEDIC, visit


View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at